Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza-Reference-Cited by-同舟云学术

Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza

Published:2016-02-08 Issue:3 Volume:2 Page:368-374
ISSN:2373-9878
Container-title:ACS Biomaterials Science & Engineering
language:en
Short-container-title:ACS Biomater. Sci. Eng.

Author:

Ross Kathleen,Adams Justin,Loyd Hyelee,Ahmed Shaheen,Sambol Anthony,Broderick Scott¹,Rajan Krishna¹,Kohut Marian,Bronich Tatiana,Wannemuehler Michael J.,Carpenter Susan,Mallapragada Surya,Narasimhan Balaji

Affiliation:

1. Materials Design and Innovation, University at Buffalo—The State University of New York, Buffalo, New York 14260, United States

Funder

Telemedicine and Advanced Technology Research Center

Iowa State University Nanovaccine Initiative

Publisher

American Chemical Society (ACS)

Subject

Biomedical Engineering,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsbiomaterials.5b00477

Reference37 articles.

1. Highly Pathogenic Avian Influenza (H5N1): Pathways of Exposure at the Animal‐Human Interface, a Systematic Review

2. Reassortment between Avian H5N1 and Human H3N2 Influenza Viruses in Ferrets: a Public Health Risk Assessment

3. U.S. Food & Drug Administration. H5N1influenza virusvaccine manufactured by Sanofi Pasteur, Inc. www.fda.gov.

4. U.S. Food and Drug Administration. FDAapproves first adjuvantedvaccine for prevention of H5N1 avian influenza. www.fda.gov.

5. Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation nanovaccine induces durable immunity and protects against SARS-CoV-2;Acta Biomaterialia;2024-07

2. Exploiting cellulose-based hydrogels for sustainable, intelligent wearables in pandemic preparedness and control;European Polymer Journal;2024-05

3. Nanovaccines: A game changing approach in the fight against infectious diseases;Biomedicine & Pharmacotherapy;2023-11

4. Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines;Immunity & Ageing;2023-06-21

5. Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection;Frontiers in Immunology;2023-06-09